Literature DB >> 10562794

Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats.

Y Miyazaki1, T Adachi, J Kurata, J Utsumi, T Shichino, H Segawa.   

Abstract

Dexmedetomidine is an alpha 2 agonist and has been reported to have proconvulsant actions. To investigate the interaction of dexmedetomidine with convulsant anaesthetics, we studied effects on seizure threshold in cats during enflurane anaesthesia. Cats were prepared with chronic implantation of electrodes for recording of the cortical electroencephalogram (EEG) and midbrain reticular formation multi-unit activity (R-MUA). Seizure threshold, the reciprocal of the number of electrical stimuli required to induce generalized EEG seizure activity x 1000 (seizure induction index (SII)), was assessed. The effects of dexmedetomidine 1, 10 and 100 micrograms kg-1 i.v. and yohimbine 500 micrograms kg-1, an alpha 2 antagonist, on SII during 3.5% enflurane anaesthesia were investigated. Dexmedetomidine significantly increased SII at 10 and 100 micrograms kg-1, and this effect was reversed by yohimbine. We found that high-dose dexmedetomidine reduced seizure threshold during enflurane anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562794     DOI: 10.1093/bja/82.6.935

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Effects of the α₂-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex.

Authors:  Mitsuhiro Fukuda; Alberto L Vazquez; Xiaopeng Zong; Seong-Gi Kim
Journal:  Eur J Neurosci       Date:  2012-10-29       Impact factor: 3.386

2.  Dexmedetomidine administration in a patient with status epilepticus under color density spectral array monitoring.

Authors:  Shinju Obara; Koh Kakinouchi; Jun Honda; Yoshie Noji; Chie Hanayama; Masahiro Murakawa
Journal:  JA Clin Rep       Date:  2019-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.